Navigation Links
'Killer' B cells demonstrate evolutionary link between fish and mammal immune systems

Researchers from the University of Pennsylvania School of Veterinary Medicine have discovered a unique evolutionary link between the immune systems of fish and mammals in the form of a primitive version of B cells, white blood cells of the immune system. Their studies link the evolution of the adaptive immune system in mammals, where B cells produce antibodies to fight infection, to the more primitive innate immunity in fish, where they found that B cells take part in phagocytosis (literally: cell eating), the process by which cells of the immune system ingest foreign particles and microbes.

The finding, which appears in the online version of Nature Immunology and will be featured on the cover of the October issue, represents a sizeable evolutionary step for the mammalian immune system and offers a potential new strategy for developing much-needed fish vaccines.

"When examining fish B cells we see them actively attacking and eating foreign bodies, which is a behavior that, according to the current dogma, just shouldn't happen in B cells," said J. Oriol Sunyer, a professor in Penn Vet's Department of Pathobiology. "I believe it is evidence for a very real connection between the most primitive forms of immunological defense, which has survived in fish, and the more advanced, adaptive immune response seen in humans and other mammals."

About 400 million years ago, the earliest ancestors of modern fish split off of the evolutionary pathway that became the earliest ancestors of modern mammals. In modern mammals, the B cell is a highly adapted part of the immune system chiefly responsible for, among other things, the creation of antibodies that tag foreign particles and microbes for destruction. Mammals have phagocytic cells, but they are a specialized few cells identified apart from the complex interactions that drive other white blood cells.

Sunyer and his colleagues discovered this previously unsuspected B cell activity while examinin
'"/>

Source:University of Pennsylvania


Page: 1 2 3

Related biology news :

1. Killer B cells provide new link in the evolution of immunity
2. Wisconsin scientists grow critical nerve cells
3. Spleen may be source of versatile stem cells
4. Researchers discover way to make cells in the eye sensitive to light
5. Priming embryonic stem cells to fulfill their promise
6. Lack of enzyme turns fat cells into fat burners
7. Poor prenatal nutrition permanently damages function of insulin-producing cells in the pancreas
8. Elusive HIV shape change revealed; Key clue to how virus infects cells
9. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
10. Enzyme allows B cells to resist death, leading to leukemia
11. Scientists rid stem cell culture of key animal cells
Post Your Comments:
Breaking Biology News(10 mins):New engineering institute to modify, develop technology for the global poor 2New engineering institute to modify, develop technology for the global poor 3Synthetic protein mimics structure, function of metalloprotein in nature 2Penn, Georgia collaboration awarded $14.6 million to expand pathogen database 2Penn, Georgia collaboration awarded $14.6 million to expand pathogen database 3Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 1Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 2Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 3Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 4Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 5Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 6Photo 3A Novartis Receives FDA Approval for Valturna 28R 29 a Single Pill Combination of valsartan and aliskiren to Treat High Blood Pressure 14132 7Study Links Epilepsy to Brain Protein 57562 1Long time QHR Hospital Client Cary Medical Center Recognized with Top Leadership Team Award 57558 1Long time QHR Hospital Client Cary Medical Center Recognized with Top Leadership Team Award 57558 2Long time QHR Hospital Client Cary Medical Center Recognized with Top Leadership Team Award 57558 3Long time QHR Hospital Client Cary Medical Center Recognized with Top Leadership Team Award 57558 4